RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer

NCT05996952 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

77

Enrollment

OTHER

Sponsor class

Conditions

Non-muscle Invasive Bladder Cancer

Interventions

DRUG: RC48-ADC

Sponsor

West China Hospital

Collaborators

[object Object]